Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Selgas

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Insulin influence (used as an additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patientsR Selgas, A Lopez-Rivas, F Alvaro, et al.
Advances in Renal Replacement Therapy|August 1, 1998
Stability of the peritoneal membrane in long-term peritoneal dialysis patientsR Selgas, M A Bajo, A Paiva, et al.
Nephron|January 1, 1991
Osteocalcin levels in uremic patients: influence of calcitriol treatment through two different routes and type of dialysisM E Martinez, R Selgas, J L Miguel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1989
Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitisR Selgas, J Muñoz, S Cigarran, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1994
Growth hormone and cortisol secretion before and after erythropoietin therapy in CAPD patientsJ J Diez, P Iglesias, J Sastre, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patientsJ J Díez, P Iglesias, J Sastre, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|April 5, 2011
[Co-inheritance of autosomal dominant polycystic kidney disease and sickle cell trait in African Americans]R Peces, C Peces, E Cuesta-López, et al.
Medicina Clinica|July 1, 1982
[Protein loss during maintenance peritoneal dialysis (author's transl)]R Selgas, J M Beberide, A Villar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1998
Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parametersA Aguilera, R Codoceo, R Selgas, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Adequacy of peritoneal dialysis: does kt/v have the same predictive value as in HD? A multicenter studyF De Alvaro, M A Bajo, F Alvarez-Ude, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Insulin influence (used as an additive to dialysate) on the mitogenic-induced effect of the peritoneal effluent in CAPD patientsR Selgas, A Lopez-Rivas, F Alvaro, et al.
Advances in Renal Replacement Therapy|August 1, 1998
Stability of the peritoneal membrane in long-term peritoneal dialysis patientsR Selgas, M A Bajo, A Paiva, et al.
Nephron|January 1, 1991
Osteocalcin levels in uremic patients: influence of calcitriol treatment through two different routes and type of dialysisM E Martinez, R Selgas, J L Miguel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1989
Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitisR Selgas, J Muñoz, S Cigarran, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1994
Growth hormone and cortisol secretion before and after erythropoietin therapy in CAPD patientsJ J Diez, P Iglesias, J Sastre, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patientsJ J Díez, P Iglesias, J Sastre, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|April 5, 2011
[Co-inheritance of autosomal dominant polycystic kidney disease and sickle cell trait in African Americans]R Peces, C Peces, E Cuesta-López, et al.
Medicina Clinica|July 1, 1982
[Protein loss during maintenance peritoneal dialysis (author's transl)]R Selgas, J M Beberide, A Villar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1998
Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parametersA Aguilera, R Codoceo, R Selgas, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Adequacy of peritoneal dialysis: does kt/v have the same predictive value as in HD? A multicenter studyF De Alvaro, M A Bajo, F Alvarez-Ude, et al.
Pageof 19